Dialysis

Recent JAMA Study: Association Between Dialysis Facility Ownership and Access to Kidney Transplantation

A study released earlier this week in JAMA studied the question of whether dialysis facility ownership is associated with access to kidney transplantation.

Joint ASPN/ASN Statement sent to the House Oversight Committee criticizing the ending of the deferred medical action policy for immigrants

On Monday September 2nd, the Trump Administration announced a change to a policy that allowed immigrants to receive a temporary reprieve from deportation while receiving life-savings medical care in the US.

A New Report From the Kidney Health Initiative Targets Innovations In Fluid Management

Fluid management is an area ripe for innovation that has a significant impact on the quality of life of people with kidney failure. The Kidney Health Initiative (KHI) recently released a supplement to its Technology Roadmap for Innovative Approaches to Renal Replacement Therapy entitled Fostering Innovation in Fluid Management.

Advancing Nephrology: Division Leaders Advise ASN

Asserting the value of nephrology

Physician productivity and compensation

Financial support of educational effort

Recruitment, retention, diversity and inclusion

Ensuring that Nephrology fellowship programs provide quality training in all aspects of kidney care

ASN Policy Q&A on the Advancing American Kidney Health initiative: Part 2

In order to double the number of kidneys available for transplant by 2030, the Administration is looking to increase the utilization of available organs from both deceased and living donors in multiple ways including, but not limited to:...

ASN launches new initiative aiming to save lives of people suffering with acute kidney injury

Made possible by a grant from Baxter Healthcare Corporation, the effort called AKI!Now: Promoting Excellence in the Prevention and Treatment of Acute Kidney Injury, will aim to help people suffering from acute kidney injury (AKI).

ASN Policy Q&A on the Advancing American Kidney Health initiative: Part 1

The American Society of Nephrology (ASN) Department of Policy and Public Affairs team has received numerous questions from interested members and from the broader kidney community on the recent Executive Order on Advancing American Kidney Health...

Overview: Advancing American Kidney Health initiative

AAKHI.PNGIn the first major transformation in kidney care in almost 50 years, the Trump Administration announced the Advancing the American Kidney Health initiative on July 10, 2019. The comprehensive kidney health strategy will bring sweeping changes to care for people with kidney diseases, including more choices for dialysis modalities, greater access to transplantation, and concerted support for development of innovative therapies, including artificial kidneys.

Dr. Reshma Kewalramani named incoming president and CEO of Vertex Pharmaceuticals, former member ASN KHI Board of Directors

Announced July 25, Dr. Reshma Kewalramani will be promoted to president and CEO of Vertex Pharmaceuticals. She is currently the chief medical officer for the company and was previously a practicing nephrologist who earned her medical doctorate at Boston University and trained at Bigham & Women’s Hospital.

Dr. Kewalramani will be the first woman to run a large biotechnology firm. Vortex’s share price “rose 360% and its sales doubled to $3 billion annually” under the previous CEO, largely due the company’s pharmaceuticals used to treat cystic fibrosis.

In Case You Missed It: Exclusive ASN Webinar on Advancing American Kidney Health

On July 26, 2019, the ASN policy team hosted anexclusive webinar discussing the Advancing American Kidney Health initiative. Click to see the slides used during the presentation. EAGnfkXW4AQEvvp_0.jpg

Pages